首页 > 最新文献

Journal of molecular and cellular cardiology最新文献

英文 中文
PERM1 regulates mitochondrial energetics through O-GlcNAcylation in the heart PERM1 通过 O-GlcNAcylation 调节心脏线粒体能量
IF 4.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-23 DOI: 10.1016/j.yjmcc.2024.11.002
Karthi Sreedevi , Amina James , Sara Do , Shreya Yedla , Sumaita Arowa , Shin-ichi Oka , Adam R. Wende , Alexey V. Zaitsev , Junco S. Warren
PERM1 was initially identified as a new downstream target of PGC-1α and ERRs that regulates mitochondrial bioenergetics in skeletal muscle. Subsequently, we and other groups demonstrated that PERM1 is also a positive regulator of mitochondrial bioenergetics in the heart. However, the exact mechanisms of regulatory functions of PERM1 remain poorly understood. O-GlcNAcylation is a post-translational modification of proteins that are regulated by two enzymes: O-GlcNAc transferase (OGT) that adds O-GlcNAc to proteins; O-GlcNAcase (OGA) that removes O-GlcNAc from proteins. O-GlcNAcylation is a powerful signaling mechanism mediating cellular responses to stressors and nutrient availability, which, among other targets, may influence cardiac metabolism. We hypothesized that PERM1 regulates mitochondrial energetics in cardiomyocytes through modulation of O-GlcNAcylation. We found that overexpression of PERM1 decreased the total levels of O-GlcNAcylated proteins, concomitant with decreased OGT and increased OGA expression levels. Luciferase gene reporter assay showed that PERM1 significantly decreases the promoter activity of Ogt without changing the promoter activity of Oga. The downregulation of OGT by PERM1 overexpression was mediated through its interaction with E2F1, a known transcription repressor of Ogt. A deliberate increase of O-GlcNAcylation through Oga silencing in cardiomyocytes decreased the basal and maximal mitochondrial respiration and ATP production rates, all of which were completely restored by PERM1 overexpression. Furthermore, excessive O-GlcNAcylation caused by the loss of PERM1 led to the increase of O-GlcNAcylated PGC-1α, a master regulator of mitochondrial bioenergetics, concurrent with the dissociation of PGC-1α from PPARα, a well-known transcription factor that regulates fatty acid β-oxidation. We conclude that PERM1 positively regulates mitochondrial energetics, in part, via suppressing O-GlcNAcylation in cardiac myocytes.
PERM1 最初被确定为 PGC-1α 和ERRs 的一个新下游靶点,可调节骨骼肌线粒体的生物能。随后,我们和其他研究小组证实,PERM1 也是心脏线粒体生物能的正向调节因子。然而,人们对 PERM1 调节功能的确切机制仍然知之甚少。O-GlcNAcylation 是蛋白质的一种翻译后修饰,由两种酶调节:O-GlcNAc转移酶(OGT)将O-GlcNAc添加到蛋白质中;O-GlcNAcase(OGA)将O-GlcNAc从蛋白质中去除。O-GlcNAcylation 是一种强大的信号机制,可介导细胞对应激源和营养供应的反应,除其他目标外,它还可能影响心脏的新陈代谢。我们假设 PERM1 通过调节 O-GlcNAcylation 来调节心肌细胞线粒体的能量。我们发现,过表达 PERM1 会降低 O-GlcNAcylated 蛋白的总水平,同时降低 OGT 和提高 OGA 的表达水平。荧光素酶基因报告实验表明,PERM1 能显著降低 Ogt 的启动子活性,而不改变 Oga 的启动子活性。PERM1 过表达对 OGT 的下调是通过其与已知的 Ogt 转录抑制因子 E2F1 的相互作用来介导的。 通过沉默 Oga 故意增加心肌细胞中的 O-GlcNAcylation 会降低线粒体的基础呼吸率和最大呼吸率以及 ATP 生成率,而 PERM1 过表达则可完全恢复这些呼吸率和 ATP 生成率。此外,PERM1 的缺失导致的过度 O-GlcNAcylation 增加了线粒体生物能的主要调节因子 PGC-1α 的 O-GlcNAcylated,同时 PGC-1α 与 PPARα 分离,而 PPARα 是众所周知的调节脂肪酸 β 氧化的转录因子。我们的结论是,PERM1 部分通过抑制心肌细胞中的 O-GlcNAcylation 积极调节线粒体能量。
{"title":"PERM1 regulates mitochondrial energetics through O-GlcNAcylation in the heart","authors":"Karthi Sreedevi ,&nbsp;Amina James ,&nbsp;Sara Do ,&nbsp;Shreya Yedla ,&nbsp;Sumaita Arowa ,&nbsp;Shin-ichi Oka ,&nbsp;Adam R. Wende ,&nbsp;Alexey V. Zaitsev ,&nbsp;Junco S. Warren","doi":"10.1016/j.yjmcc.2024.11.002","DOIUrl":"10.1016/j.yjmcc.2024.11.002","url":null,"abstract":"<div><div>PERM1 was initially identified as a new downstream target of PGC-1α and ERRs that regulates mitochondrial bioenergetics in skeletal muscle. Subsequently, we and other groups demonstrated that PERM1 is also a positive regulator of mitochondrial bioenergetics in the heart. However, the exact mechanisms of regulatory functions of PERM1 remain poorly understood. O-GlcNAcylation is a post-translational modification of proteins that are regulated by two enzymes: O-GlcNAc transferase (OGT) that adds O-GlcNAc to proteins; O-GlcNAcase (OGA) that removes O-GlcNAc from proteins. O-GlcNAcylation is a powerful signaling mechanism mediating cellular responses to stressors and nutrient availability, which, among other targets, may influence cardiac metabolism. We hypothesized that PERM1 regulates mitochondrial energetics in cardiomyocytes through modulation of O-GlcNAcylation. We found that overexpression of PERM1 decreased the total levels of O-GlcNAcylated proteins, concomitant with decreased OGT and increased OGA expression levels. Luciferase gene reporter assay showed that PERM1 significantly decreases the promoter activity of <em>Ogt</em> without changing the promoter activity of <em>Oga</em>. The downregulation of OGT by PERM1 overexpression was mediated through its interaction with E2F1, a known transcription repressor of <em>Ogt</em>. A deliberate increase of O-GlcNAcylation through <em>Oga</em> silencing in cardiomyocytes decreased the basal and maximal mitochondrial respiration and ATP production rates, all of which were completely restored by PERM1 overexpression. Furthermore, excessive O-GlcNAcylation caused by the loss of PERM1 led to the increase of O-GlcNAcylated PGC-1α, a master regulator of mitochondrial bioenergetics, concurrent with the dissociation of PGC-1α from PPARα, a well-known transcription factor that regulates fatty acid β-oxidation. We conclude that PERM1 positively regulates mitochondrial energetics, in part, via suppressing O-GlcNAcylation in cardiac myocytes.</div></div>","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"198 ","pages":"Pages 1-12"},"PeriodicalIF":4.9,"publicationDate":"2024-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142701080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to "PGE2 protects against heart failure through inhibiting TGF-β1 synthesis in cardiomyocytes and crosstalk between TGF-β1 and GRK2" [Journal of Molecular and Cellular Cardiology. 172(2022) 63-77]. PGE2 通过抑制心肌细胞中 TGF-β1 的合成和 TGF-β1 与 GRK2 之间的串扰保护心衰》的更正 [《分子和细胞心脏病学杂志》。
IF 4.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-22 DOI: 10.1016/j.yjmcc.2024.11.003
Jing Fu, Li Li, Long Chen, Congping Su, Xiuling Feng, Kai Huang, Laxi Zhang, Xiaoyan Yang, Qin Fu
{"title":"Corrigendum to \"PGE2 protects against heart failure through inhibiting TGF-β1 synthesis in cardiomyocytes and crosstalk between TGF-β1 and GRK2\" [Journal of Molecular and Cellular Cardiology. 172(2022) 63-77].","authors":"Jing Fu, Li Li, Long Chen, Congping Su, Xiuling Feng, Kai Huang, Laxi Zhang, Xiaoyan Yang, Qin Fu","doi":"10.1016/j.yjmcc.2024.11.003","DOIUrl":"https://doi.org/10.1016/j.yjmcc.2024.11.003","url":null,"abstract":"","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142695360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retraction notice to “The novel antibody fusion protein rhNRG1-HER3i promotes heart regeneration by enhancing NRG1-ERBB4 signaling pathway” [Journal of Molecular and Cellular Cardiology 187 (2023) 26–37] 新型抗体融合蛋白 rhNRG1-HER3i 通过增强 NRG1-ERBB4 信号通路促进心脏再生》[《分子和细胞心脏病学杂志》187 (2023) 26-37] 撤稿通知。
IF 4.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-17 DOI: 10.1016/j.yjmcc.2024.09.009
Xuemei Wang , Hao Wu , Luxun Tang , Wenbin Fu , Yanji He , Chunyu Zeng , Wei Eric Wang
{"title":"Retraction notice to “The novel antibody fusion protein rhNRG1-HER3i promotes heart regeneration by enhancing NRG1-ERBB4 signaling pathway” [Journal of Molecular and Cellular Cardiology 187 (2023) 26–37]","authors":"Xuemei Wang ,&nbsp;Hao Wu ,&nbsp;Luxun Tang ,&nbsp;Wenbin Fu ,&nbsp;Yanji He ,&nbsp;Chunyu Zeng ,&nbsp;Wei Eric Wang","doi":"10.1016/j.yjmcc.2024.09.009","DOIUrl":"10.1016/j.yjmcc.2024.09.009","url":null,"abstract":"","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"197 ","pages":"Page 151"},"PeriodicalIF":4.9,"publicationDate":"2024-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exercise training attenuates cardiac dysfunction induced by excessive sympathetic activation through an AMPK-KLF4-FMO2 axis 通过AMPK-KLF4-FMO2轴,运动训练可减轻交感神经过度激活引起的心脏功能障碍。
IF 4.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-02 DOI: 10.1016/j.yjmcc.2024.10.015
Shiyu Fan , Mingming Zhao , Kang Wang , Yawen Deng , Xiaoyue Yu , Ketao Ma , Youyi Zhang , Han Xiao
Cardiovascular diseases (CVDs) are a leading cause of mortality worldwide and are associated with an overactivated sympathetic system. Although exercise training has shown promise in mitigating sympathetic stress-induced cardiac remodeling, the precise mechanisms remain elusive. Here, we demonstrate that exercise significantly upregulates cardiac flavin-containing monooxygenase 2 (FMO2) expression. Notably, we find that exercise training effectively counteracts sympathetic overactivation-induced cardiac dysfunction and fibrosis by enhancing FMO2 expression via adenosine 5′-monophosphate (AMP)-activated protein kinase (AMPK) activation. Functional investigations employing FMO2 knockdown with adeno-associated virus 9 (AAV9) underscore the necessity for FMO2 expression to protect the heart during exercise in vivo. Furthermore, we identify the krüppel-like factor 4 (KLF4) as a transcriptional mediator of FMO2 that is crucial for the mechanism through which AMPK activation protects against sympathetic overactivation-induced cardiac dysfunction and fibrosis. Taken together, our study reveals a cardioprotective mechanism for exercise training through an AMPK-KLF4-FMO2 signaling pathway that underscores how exercise alleviates cardiac dysfunction induced by excessive sympathetic activation.
心血管疾病(CVD)是导致全球死亡的主要原因,与交感神经系统过度激活有关。虽然运动训练有望减轻交感神经压力诱导的心脏重塑,但其确切机制仍难以捉摸。在这里,我们证明了运动能显著上调心脏含黄素单加氧酶 2(FMO2)的表达。值得注意的是,我们发现运动训练可通过激活腺苷-5'-单磷酸(AMP)激活蛋白激酶(AMPK)来提高FMO2的表达,从而有效抵消交感神经过度激活诱导的心功能障碍和纤维化。利用腺相关病毒9(AAV9)敲除FMO2的功能研究强调了FMO2的表达对于在体内运动时保护心脏的必要性。此外,我们还发现克鲁佩尔样因子 4(KLF4)是 FMO2 的转录介质,对于 AMPK 激活保护交感神经过度激活诱发的心脏功能障碍和纤维化的机制至关重要。综上所述,我们的研究揭示了运动训练通过 AMPK-KLF4-FMO2 信号通路保护心脏的机制,强调了运动如何缓解交感神经过度激活诱导的心脏功能障碍。
{"title":"Exercise training attenuates cardiac dysfunction induced by excessive sympathetic activation through an AMPK-KLF4-FMO2 axis","authors":"Shiyu Fan ,&nbsp;Mingming Zhao ,&nbsp;Kang Wang ,&nbsp;Yawen Deng ,&nbsp;Xiaoyue Yu ,&nbsp;Ketao Ma ,&nbsp;Youyi Zhang ,&nbsp;Han Xiao","doi":"10.1016/j.yjmcc.2024.10.015","DOIUrl":"10.1016/j.yjmcc.2024.10.015","url":null,"abstract":"<div><div>Cardiovascular diseases (CVDs) are a leading cause of mortality worldwide and are associated with an overactivated sympathetic system. Although exercise training has shown promise in mitigating sympathetic stress-induced cardiac remodeling, the precise mechanisms remain elusive. Here, we demonstrate that exercise significantly upregulates cardiac flavin-containing monooxygenase 2 (FMO2) expression. Notably, we find that exercise training effectively counteracts sympathetic overactivation-induced cardiac dysfunction and fibrosis by enhancing FMO2 expression via adenosine 5′-monophosphate (AMP)-activated protein kinase (AMPK) activation. Functional investigations employing FMO2 knockdown with adeno-associated virus 9 (AAV9) underscore the necessity for FMO2 expression to protect the heart during exercise in vivo. Furthermore, we identify the krüppel-like factor 4 (KLF4) as a transcriptional mediator of FMO2 that is crucial for the mechanism through which AMPK activation protects against sympathetic overactivation-induced cardiac dysfunction and fibrosis. Taken together, our study reveals a cardioprotective mechanism for exercise training through an AMPK-KLF4-FMO2 signaling pathway that underscores how exercise alleviates cardiac dysfunction induced by excessive sympathetic activation.</div></div>","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"197 ","pages":"Pages 136-149"},"PeriodicalIF":4.9,"publicationDate":"2024-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142566354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Different effects of cardiomyocyte contractile activity on transverse and axial tubular system luminal content dynamics 心肌细胞收缩活动对横向和轴向肾小管系统管腔内容物动态的不同影响
IF 4.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-02 DOI: 10.1016/j.yjmcc.2024.10.014
J. Greiner , M. Dente , S. Orós-Rodrigo , B.A. Cameron , J. Madl , W. Kaltenbacher , T. Kok , C.M. Zgierski-Johnston , R. Peyronnet , P. Kohl , L. Sacconi , E.A. Rog-Zielinska

Background

Efficient excitation-contraction coupling of mammalian ventricular cardiomyocytes depends on the transverse-axial tubular system (TATS), a network of surface membrane invaginations. TATS enables tight coupling of sarcolemmal and sarcoplasmic reticulum membranes, which is essential for rapid Ca2+-induced Ca2+ release, and uniform contraction upon electrical stimulation. The majority of TATS in healthy ventricular cardiomyocytes is composed of transverse tubules (TT, ∼90 % of TATS in rabbit). The remainder consists of mostly axial tubules (AT), which are less abundant and less well studied. In disease, however, the relative abundance of TT and AT changes. The mechanisms and relevance of this change are not known, and understanding them requires a more targeted effort to study the dynamics of AT structure and function.
While TATS content is continuous with the interstitial space, it is contained within a domain of restricted diffusion. We have previously shown that TT are cyclically squeezed during stretch and contraction. This can contribute to TT content mixing and accelerates luminal content exchange with the environment. Here, we explore the effects of cardiomyocyte stretch and contraction on AT.

Methods

TATS structure and diffusion dynamics were studied using 3D electron tomography of rabbit left ventricular cardiomyocytes, preserved at rest or during contraction, and ventricular tissue preserved at rest or during stretch, as well as live-cell TATS content exchange measurements.

Results

We show (i) that cardiomyocyte contraction is associated with an increase in the apparent speed of diffusion of TT content that scales with beating rate and degree of cell shortening. In contrast, (ii) AT develop membrane folds and constrictions during contraction, (iii) with no effect of contraction on luminal exchange dynamics, while (iv) cardiomyocyte stretch is associated with AT straightening and AT and TT ‘squeezing’ that (v) supports an acceleration of the apparent speed of diffusion in AT and TT. Finally, (vi) we present a simple computational model outlining the potential relevance of AT in healthy and diseased cells.

Conclusions

Our results indicate that TT and AT are differently affected by the cardiac contractile cycle, and suggest that AT may play a role in ensuring TATS network content homogeneity in diseased cardiomyocytes. Further research is needed to explore the interplay of structural and functional remodelling of different TATS components in failing myocardium.
背景:哺乳动物心室心肌细胞有效的兴奋-收缩耦合取决于横轴管系统(TATS),这是一个表面膜内陷网络。TATS 使肌浆膜和肌浆网膜紧密耦合,这对 Ca2+ 诱导的 Ca2+ 快速释放和电刺激下的均匀收缩至关重要。健康心室心肌细胞中的大多数 TATS 由横向小管(TT,约占兔 TATS 的 90%)组成。其余部分主要由轴向小管(AT)组成,其数量较少,研究也较少。然而,在疾病中,TT 和 AT 的相对丰度会发生变化。这种变化的机制和相关性尚不清楚,要了解它们需要更有针对性地研究 AT 结构和功能的动态变化。虽然 TATS 的含量与间质空间是连续的,但它包含在一个扩散受限的区域内。我们之前已经证明,TT 在拉伸和收缩过程中会受到周期性挤压。这可能会导致 TT 成分混合,并加速管腔成分与环境的交换。在此,我们探讨了心肌细胞拉伸和收缩对 AT 的影响:方法:使用三维电子断层扫描技术研究了兔左心室心肌细胞在静止或收缩时的TATS结构和扩散动力学,以及心室组织在静止或拉伸时的TATS含量交换活细胞测量:结果:我们发现:(i) 心肌细胞收缩与 TT 含量表观扩散速度的增加有关,该速度与跳动率和细胞缩短程度成比例。相反,(ii) AT 在收缩过程中出现膜褶皱和收缩,(iii) 收缩对管腔交换动力学没有影响,而(iv) 心肌细胞拉伸与 AT 变直以及 AT 和 TT "挤压 "有关,(v) 支持 AT 和 TT 表观扩散速度的加快。最后,(vi) 我们提出了一个简单的计算模型,概述了 AT 在健康和患病细胞中的潜在相关性:我们的研究结果表明,TT 和 AT 受心脏收缩周期的影响不同,并表明 AT 可能在确保病变心肌细胞中 TATS 网络内容均一性方面发挥作用。需要进一步研究探讨衰竭心肌中不同 TATS 成分的结构和功能重塑的相互作用。
{"title":"Different effects of cardiomyocyte contractile activity on transverse and axial tubular system luminal content dynamics","authors":"J. Greiner ,&nbsp;M. Dente ,&nbsp;S. Orós-Rodrigo ,&nbsp;B.A. Cameron ,&nbsp;J. Madl ,&nbsp;W. Kaltenbacher ,&nbsp;T. Kok ,&nbsp;C.M. Zgierski-Johnston ,&nbsp;R. Peyronnet ,&nbsp;P. Kohl ,&nbsp;L. Sacconi ,&nbsp;E.A. Rog-Zielinska","doi":"10.1016/j.yjmcc.2024.10.014","DOIUrl":"10.1016/j.yjmcc.2024.10.014","url":null,"abstract":"<div><h3>Background</h3><div>Efficient excitation-contraction coupling of mammalian ventricular cardiomyocytes depends on the transverse-axial tubular system (TATS), a network of surface membrane invaginations. TATS enables tight coupling of sarcolemmal and sarcoplasmic reticulum membranes, which is essential for rapid Ca<sup>2+</sup>-induced Ca<sup>2+</sup> release, and uniform contraction upon electrical stimulation. The majority of TATS in healthy ventricular cardiomyocytes is composed of transverse tubules (TT, ∼90 % of TATS in rabbit). The remainder consists of mostly axial tubules (AT), which are less abundant and less well studied. In disease, however, the relative abundance of TT and AT changes. The mechanisms and relevance of this change are not known, and understanding them requires a more targeted effort to study the dynamics of AT structure and function.</div><div>While TATS content is continuous with the interstitial space, it is contained within a domain of restricted diffusion. We have previously shown that TT are cyclically squeezed during stretch and contraction. This can contribute to TT content mixing and accelerates luminal content exchange with the environment. Here, we explore the effects of cardiomyocyte stretch and contraction on AT.</div></div><div><h3>Methods</h3><div>TATS structure and diffusion dynamics were studied using 3D electron tomography of rabbit left ventricular cardiomyocytes, preserved at rest or during contraction, and ventricular tissue preserved at rest or during stretch, as well as live-cell TATS content exchange measurements.</div></div><div><h3>Results</h3><div>We show (i) that cardiomyocyte contraction is associated with an increase in the apparent speed of diffusion of TT content that scales with beating rate and degree of cell shortening. In contrast, (ii) AT develop membrane folds and constrictions during contraction, (iii) with no effect of contraction on luminal exchange dynamics, while (iv) cardiomyocyte stretch is associated with AT straightening and AT and TT ‘squeezing’ that (v) supports an acceleration of the apparent speed of diffusion in AT and TT. Finally, (vi) we present a simple computational model outlining the potential relevance of AT in healthy and diseased cells.</div></div><div><h3>Conclusions</h3><div>Our results indicate that TT and AT are differently affected by the cardiac contractile cycle, and suggest that AT may play a role in ensuring TATS network content homogeneity in diseased cardiomyocytes. Further research is needed to explore the interplay of structural and functional remodelling of different TATS components in failing myocardium.</div></div>","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"197 ","pages":"Pages 125-135"},"PeriodicalIF":4.9,"publicationDate":"2024-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Macrophages in the infarcted heart acquire a fibrogenic phenotype, expressing matricellular proteins, but do not undergo fibroblast conversion 梗塞心脏中的巨噬细胞获得纤维表型,表达母细胞蛋白,但不会发生成纤维细胞转化。
IF 4.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-01 DOI: 10.1016/j.yjmcc.2024.07.010
Ruoshui Li , Anis Hanna , Shuaibo Huang , Silvia C. Hernandez , Izabela Tuleta , Akihiko Kubota , Claudio Humeres , Bijun Chen , Yang Liu , Deyou Zheng , Nikolaos G. Frangogiannis
Although some studies have suggested that macrophages may secrete structural collagens, and convert to fibroblast-like cells, macrophage to fibroblast transdifferentiation in infarcted and remodeling hearts remains controversial. Our study uses linage tracing approaches and single cell transcriptomics to examine whether macrophages undergo fibroblast conversion, and to characterize the extracellular matrix expression profile of myeloid cells in myocardial infarction. To examine whether infarct macrophages undergo fibroblast conversion, we identified macrophage-derived progeny using the inducible CX3CR1CreER mice crossed with the PDGFRαEGFP reporter line for reliable fibroblast identification. The abundant fibroblasts that infiltrated the infarcted myocardium after 7 and 28 days of coronary occlusion were not derived from CX3CR1+ macrophages. Infarct macrophages retained myeloid cell characteristics and did not undergo conversion to myofibroblasts, endothelial or vascular mural cells. Single cell RNA-seq of CSF1R+ myeloid cells harvested from control and infarcted hearts showed no significant expression of fibroblast identity genes by myeloid cell clusters. Moreover, infarct macrophages did not express significant levels of genes encoding structural collagens. However, infarct macrophage and monocyte clusters were the predominant source of the fibrogenic growth factors Tgfb1 and Pdgfb, and of the matricellular proteins Spp1/Osteopontin, Thbs1/Thrombospondin-1, Emilin2, and Fn1/fibronectin, while expressing significant amounts of several other matrix genes, including Vcan/versican, Ecm1 and Sparc. ScRNA-seq data suggested similar patterns of matrix gene expression in human myocardial infarction. In conclusion, infarct macrophages do not undergo fibroblast or myofibroblast conversion and do not exhibit upregulation of structural collagens but may contribute to fibrotic remodeling by producing several fibrogenic matricellular proteins.
尽管一些研究表明巨噬细胞可分泌结构性胶原并转化为成纤维细胞样细胞,但在梗死和重塑心脏中巨噬细胞向成纤维细胞的转分化仍存在争议。我们的研究采用血系追踪方法和单细胞转录组学研究巨噬细胞是否发生成纤维细胞转化,并描述心肌梗死中髓系细胞细胞外基质的表达谱。为了研究梗死巨噬细胞是否会发生成纤维细胞转化,我们使用诱导型 CX3CR1CreER 小鼠与 PDGFRαEGFP 报告基因杂交,对巨噬细胞衍生的后代进行了可靠的成纤维细胞鉴定。冠状动脉闭塞 7 天和 28 天后浸润梗死心肌的大量成纤维细胞并非来自 CX3CR1+ 巨噬细胞。梗死的巨噬细胞保留了髓样细胞的特征,没有转化为肌成纤维细胞、内皮细胞或血管壁细胞。从对照组和梗死心脏中提取的CSF1R+髓系细胞的单细胞RNA-seq显示,髓系细胞集群没有明显的成纤维细胞特征基因表达。此外,梗死巨噬细胞也没有表达大量编码结构胶原的基因。然而,梗死巨噬细胞和单核细胞集群是纤维生长因子Tgfb1和Pdgfb以及基质蛋白Spp1/Osteopontin、Thbs1/Thrombospondin-1、Emilin2和Fn1/纤连蛋白的主要来源,同时表达大量其他几个基质基因,包括Vcan/versican、Ecm1和Sparc。ScRNA-seq数据表明,人类心肌梗死中基质基因的表达模式与此类似。总之,梗死巨噬细胞不会发生成纤维细胞或成肌纤维细胞的转化,也不会表现出结构胶原的上调,但可能会通过产生几种纤维母细胞蛋白来促进纤维化重塑。
{"title":"Macrophages in the infarcted heart acquire a fibrogenic phenotype, expressing matricellular proteins, but do not undergo fibroblast conversion","authors":"Ruoshui Li ,&nbsp;Anis Hanna ,&nbsp;Shuaibo Huang ,&nbsp;Silvia C. Hernandez ,&nbsp;Izabela Tuleta ,&nbsp;Akihiko Kubota ,&nbsp;Claudio Humeres ,&nbsp;Bijun Chen ,&nbsp;Yang Liu ,&nbsp;Deyou Zheng ,&nbsp;Nikolaos G. Frangogiannis","doi":"10.1016/j.yjmcc.2024.07.010","DOIUrl":"10.1016/j.yjmcc.2024.07.010","url":null,"abstract":"<div><div>Although some studies have suggested that macrophages may secrete structural collagens, and convert to fibroblast-like cells, macrophage to fibroblast transdifferentiation in infarcted and remodeling hearts remains controversial. Our study uses linage tracing approaches and single cell transcriptomics to examine whether macrophages undergo fibroblast conversion, and to characterize the extracellular matrix expression profile of myeloid cells in myocardial infarction. To examine whether infarct macrophages undergo fibroblast conversion, we identified macrophage-derived progeny using the inducible CX3CR1<sup>CreER</sup> mice crossed with the PDGFRα<sup>EGFP</sup> reporter line for reliable fibroblast identification. The abundant fibroblasts that infiltrated the infarcted myocardium after 7 and 28 days of coronary occlusion were not derived from CX3CR1+ macrophages. Infarct macrophages retained myeloid cell characteristics and did not undergo conversion to myofibroblasts, endothelial or vascular mural cells. Single cell RNA-seq of CSF1R+ myeloid cells harvested from control and infarcted hearts showed no significant expression of fibroblast identity genes by myeloid cell clusters. Moreover, infarct macrophages did not express significant levels of genes encoding structural collagens. However, infarct macrophage and monocyte clusters were the predominant source of the fibrogenic growth factors <em>Tgfb1</em> and <em>Pdgfb,</em> and of the matricellular proteins <em>Spp1</em>/Osteopontin, <em>Thbs1</em>/Thrombospondin-1, <em>Emilin2</em>, and <em>Fn1</em>/fibronectin, while expressing significant amounts of several other matrix genes, including <em>Vcan</em>/versican, <em>Ecm1</em> and <em>Sparc</em>. ScRNA-seq data suggested similar patterns of matrix gene expression in human myocardial infarction. In conclusion, infarct macrophages do not undergo fibroblast or myofibroblast conversion and do not exhibit upregulation of structural collagens but may contribute to fibrotic remodeling by producing several fibrogenic matricellular proteins.</div></div>","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"196 ","pages":"Pages 152-167"},"PeriodicalIF":4.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141875092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac macrophages and fibroblasts: A synergistic partnership without cellular transition 心脏巨噬细胞和成纤维细胞:无细胞转换的协同合作关系
IF 4.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-01 DOI: 10.1016/j.yjmcc.2024.09.008
Daniel A. Kasprovic , Robert M. Jaggers , Michael Tranter , Onur Kanisicak
{"title":"Cardiac macrophages and fibroblasts: A synergistic partnership without cellular transition","authors":"Daniel A. Kasprovic ,&nbsp;Robert M. Jaggers ,&nbsp;Michael Tranter ,&nbsp;Onur Kanisicak","doi":"10.1016/j.yjmcc.2024.09.008","DOIUrl":"10.1016/j.yjmcc.2024.09.008","url":null,"abstract":"","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"196 ","pages":"Pages 168-170"},"PeriodicalIF":4.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142289359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrated proteomics and transcriptomics analysis reveals insights into differences in premature mortality associated with disparate pathogenic RBM20 variants 蛋白质组学和转录组学综合分析揭示了与不同致病基因 RBM20 变体相关的过早死亡率差异
IF 4.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-28 DOI: 10.1016/j.yjmcc.2024.10.013
Zachery R. Gregorich , Eli J. Larson , Yanghai Zhang , Camila U. Braz , Chunling Liu , Ying Ge , Wei Guo
Variants in RNA binding motif protein 20 (RBM20) are causative in a severe form of dilated cardiomyopathy referred to as RBM20 cardiomyopathy, yet the mechanisms are unclear. Moreover, the reason(s) for phenotypic heterogeneity in carriers with different pathogenic variants are similarly opaque. To gain insight, we carried out multi-omics analysis, including the first analysis of gene expression changes at the protein level, of mice carrying two different pathogenic variants in the RBM20 nuclear localization signal (NLS). Direct comparison of the phenotypes confirmed greater premature morality in S639G variant carrying mice compared to mice with the S637A variant despite similar cardiac remodeling and dysfunction. Analysis of differentially spliced genes uncovered alterations in the splicing of both RBM20 target genes and non-target genes, including several genes previously implicated in arrhythmia. Global proteomics analysis found that a greater number of proteins were differentially expressed in the hearts of Rbm20S639G mice relative to WT than in Rbm20S637A versus WT. Gene ontology analysis suggested greater mitochondrial dysfunction in Rbm20S639G mice, although direct comparison of protein expression in the hearts of Rbm20S639G versus Rbm20S637A mice failed to identify any significant differences. Similarly, few differences were found by direct comparison of gene expression at the transcript level in Rbm20S639G and Rbm20S637A despite greater coverage. Our data provide a comprehensive overview of gene splicing and expression differences associated with pathogenic variants in RBM20, as well as insights into the molecular underpinnings of phenotypic heterogeneity associated with different dilated cardiomyopathy-associated variants.
RNA 结合基调蛋白 20(RBM20)变异是一种严重扩张型心肌病(称为 RBM20 心肌病)的致病因子,但其机制尚不清楚。此外,不同致病变体携带者表型异质性的原因也同样不清楚。为了深入了解这一问题,我们对携带 RBM20 核定位信号(NLS)两种不同致病变体的小鼠进行了多组学分析,包括首次分析蛋白质水平的基因表达变化。表型的直接比较证实,与携带 S637A 变异的小鼠相比,携带 S639G 变异的小鼠过早死亡率更高,尽管心脏重塑和功能障碍相似。对不同剪接基因的分析发现,RBM20靶基因和非靶基因的剪接都发生了改变,其中包括几个以前与心律失常有关的基因。全局蛋白质组学分析发现,Rbm20S639G 小鼠心脏中相对于 WT 有差异表达的蛋白质数量多于 Rbm20S637A 相对于 WT。基因本体分析表明,Rbm20S639G 小鼠的线粒体功能障碍更严重,但直接比较 Rbm20S639G 与 Rbm20S637A 小鼠心脏中的蛋白质表达,未能发现任何显著差异。同样,通过直接比较 Rbm20S639G 和 Rbm20S637A 在转录本水平的基因表达,尽管覆盖范围更大,但几乎没有发现差异。我们的数据全面概述了与 RBM20 致病变异相关的基因剪接和表达差异,并揭示了与不同扩张型心肌病相关变异相关的表型异质性的分子基础。
{"title":"Integrated proteomics and transcriptomics analysis reveals insights into differences in premature mortality associated with disparate pathogenic RBM20 variants","authors":"Zachery R. Gregorich ,&nbsp;Eli J. Larson ,&nbsp;Yanghai Zhang ,&nbsp;Camila U. Braz ,&nbsp;Chunling Liu ,&nbsp;Ying Ge ,&nbsp;Wei Guo","doi":"10.1016/j.yjmcc.2024.10.013","DOIUrl":"10.1016/j.yjmcc.2024.10.013","url":null,"abstract":"<div><div>Variants in RNA binding motif protein 20 (RBM20) are causative in a severe form of dilated cardiomyopathy referred to as RBM20 cardiomyopathy, yet the mechanisms are unclear. Moreover, the reason(s) for phenotypic heterogeneity in carriers with different pathogenic variants are similarly opaque. To gain insight, we carried out multi-omics analysis, including the first analysis of gene expression changes at the protein level, of mice carrying two different pathogenic variants in the RBM20 nuclear localization signal (NLS). Direct comparison of the phenotypes confirmed greater premature morality in S639G variant carrying mice compared to mice with the S637A variant despite similar cardiac remodeling and dysfunction. Analysis of differentially spliced genes uncovered alterations in the splicing of both RBM20 target genes and non-target genes, including several genes previously implicated in arrhythmia. Global proteomics analysis found that a greater number of proteins were differentially expressed in the hearts of <em>Rbm20</em><sup>S639G</sup> mice relative to WT than in <em>Rbm20</em><sup>S637A</sup> versus WT. Gene ontology analysis suggested greater mitochondrial dysfunction in <em>Rbm20</em><sup>S639G</sup> mice, although direct comparison of protein expression in the hearts of <em>Rbm20</em><sup>S639G</sup> versus <em>Rbm20</em><sup>S637A</sup> mice failed to identify any significant differences. Similarly, few differences were found by direct comparison of gene expression at the transcript level in <em>Rbm20</em><sup>S639G</sup> and <em>Rbm20</em><sup>S637A</sup> despite greater coverage. Our data provide a comprehensive overview of gene splicing and expression differences associated with pathogenic variants in RBM20, as well as insights into the molecular underpinnings of phenotypic heterogeneity associated with different dilated cardiomyopathy-associated variants.</div></div>","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"197 ","pages":"Pages 78-89"},"PeriodicalIF":4.9,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142553014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhibitory interferon regulatory factor 5 binding peptide suppresses abdominal aortic aneurysm expansion in vivo 抑制性干扰素调节因子 5 结合肽可抑制腹主动脉瘤在体内的扩张。
IF 4.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-28 DOI: 10.1016/j.yjmcc.2024.10.012
Zhen Yuan , Li Shu , Peipei Yang , Jie Sun , Mengsha Zheng , Jiantao Fu , Yidong Wang , Shen Song , Zhenjie Liu , Zhejun Cai
Abdominal aortic aneurysm (AAA) is a critical condition characterized by the expansion of the infrarenal aorta, often leading to high mortality upon rupture. The absence of treatment for asymptomatic AAAs urgently necessitates uncovering the underlying mechanisms of their development. This study utilized mice to induce AAA through porcine pancreatic elastase with BAPN feeding and found that mice receiving the IRF5-binding peptide (IBP) demonstrated significantly slowed AAA expansion and reduced adventitia degradation compared to the control group. Additionally, the IBP group showed decreased macrophage infiltration and reduced matrix metalloproteinase-9 (MMP9) activity. Targeting IRF5 with IBP offers new avenues for potential treatments for asymptomatic AAAs.
腹主动脉瘤(AAA)是一种以肾下主动脉扩张为特征的危重疾病,一旦破裂,死亡率往往很高。由于对无症状的 AAA 缺乏治疗,因此迫切需要揭示其发病机制。本研究利用小鼠通过猪胰腺弹性蛋白酶和 BAPN 喂养诱发 AAA,结果发现,与对照组相比,接受 IRF5 结合肽(IBP)治疗的小鼠明显减缓了 AAA 的扩张,减少了血管内膜的降解。此外,IBP组的巨噬细胞浸润减少,基质金属蛋白酶-9(MMP9)活性降低。用IBP靶向IRF5为无症状AAA的潜在治疗提供了新途径。
{"title":"Inhibitory interferon regulatory factor 5 binding peptide suppresses abdominal aortic aneurysm expansion in vivo","authors":"Zhen Yuan ,&nbsp;Li Shu ,&nbsp;Peipei Yang ,&nbsp;Jie Sun ,&nbsp;Mengsha Zheng ,&nbsp;Jiantao Fu ,&nbsp;Yidong Wang ,&nbsp;Shen Song ,&nbsp;Zhenjie Liu ,&nbsp;Zhejun Cai","doi":"10.1016/j.yjmcc.2024.10.012","DOIUrl":"10.1016/j.yjmcc.2024.10.012","url":null,"abstract":"<div><div>Abdominal aortic aneurysm (AAA) is a critical condition characterized by the expansion of the infrarenal aorta, often leading to high mortality upon rupture. The absence of treatment for asymptomatic AAAs urgently necessitates uncovering the underlying mechanisms of their development. This study utilized mice to induce AAA through porcine pancreatic elastase with BAPN feeding and found that mice receiving the IRF5-binding peptide (IBP) demonstrated significantly slowed AAA expansion and reduced adventitia degradation compared to the control group. Additionally, the IBP group showed decreased macrophage infiltration and reduced matrix metalloproteinase-9 (MMP9) activity. Targeting IRF5 with IBP offers new avenues for potential treatments for asymptomatic AAAs.</div></div>","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"197 ","pages":"Pages 103-107"},"PeriodicalIF":4.9,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142566355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolomics in atrial fibrillation - A review and meta-analysis of blood, tissue and animal models 心房颤动的代谢组学研究--血液、组织和动物模型的综述和荟萃分析。
IF 4.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-28 DOI: 10.1016/j.yjmcc.2024.10.011
Leonoor F.J.M. Wijdeveld , Amelie C.T. Collinet , Fabries G. Huiskes , Bianca J.J.M. Brundel

Background

Atrial fibrillation (AF) is a highly prevalent cardiac arrhythmia associated with severe cardiovascular complications. AF presents a growing global challenge, however, current treatment strategies for AF do not address the underlying pathophysiology. To advance diagnosis and treatment of AF, a deeper understanding of AF root causes is needed. Metabolomics is a fast approach to identify, quantify and analyze metabolites in a given sample, such as human serum or atrial tissue. In the past two decades, metabolomics have enabled research on metabolite biomarkers to predict AF, metabolic features of AF, and testing metabolic mechanisms of AF in animal models. Due to the field's rapid evolution, the methods of AF metabolomics studies have not always been optimal. Metabolomics research has lacked standardization and requires expertise to face methodological challenges.

Purpose of the review

We summarize and meta-analyze metabolomics research on AF in human plasma and serum, atrial tissue, and animal models. We present the current progress on metabolic biomarkers candidates, metabolic features of clinical AF, and the translation of metabolomics findings from animal to human. We additionally discuss strengths and weaknesses of the metabolomics method and highlight opportunities for future AF metabolomics research.
背景:心房颤动(房颤)是一种与严重心血管并发症相关的高发心律失常。心房颤动是一项日益严峻的全球性挑战,然而,目前的心房颤动治疗策略并未解决其潜在的病理生理学问题。要推进心房颤动的诊断和治疗,需要深入了解心房颤动的根本原因。代谢组学是一种快速识别、量化和分析特定样本(如人血清或心房组织)中代谢物的方法。在过去的二十年里,代谢组学使人们能够研究预测房颤的代谢物生物标志物、房颤的代谢特征以及在动物模型中测试房颤的代谢机制。由于该领域发展迅速,房颤代谢组学研究的方法并不总是最佳的。代谢组学研究缺乏标准化,需要专业知识来应对方法学上的挑战:我们对人体血浆和血清、心房组织以及动物模型中有关房颤的代谢组学研究进行了总结和元分析。我们介绍了候选代谢生物标记物、临床房颤的代谢特征以及代谢组学研究结果从动物到人类的转化等方面的最新进展。此外,我们还讨论了代谢组学方法的优缺点,并强调了未来房颤代谢组学研究的机遇。
{"title":"Metabolomics in atrial fibrillation - A review and meta-analysis of blood, tissue and animal models","authors":"Leonoor F.J.M. Wijdeveld ,&nbsp;Amelie C.T. Collinet ,&nbsp;Fabries G. Huiskes ,&nbsp;Bianca J.J.M. Brundel","doi":"10.1016/j.yjmcc.2024.10.011","DOIUrl":"10.1016/j.yjmcc.2024.10.011","url":null,"abstract":"<div><h3>Background</h3><div>Atrial fibrillation (AF) is a highly prevalent cardiac arrhythmia associated with severe cardiovascular complications. AF presents a growing global challenge, however, current treatment strategies for AF do not address the underlying pathophysiology. To advance diagnosis and treatment of AF, a deeper understanding of AF root causes is needed. Metabolomics is a fast approach to identify, quantify and analyze metabolites in a given sample, such as human serum or atrial tissue. In the past two decades, metabolomics have enabled research on metabolite biomarkers to predict AF, metabolic features of AF, and testing metabolic mechanisms of AF in animal models. Due to the field's rapid evolution, the methods of AF metabolomics studies have not always been optimal. Metabolomics research has lacked standardization and requires expertise to face methodological challenges.</div></div><div><h3>Purpose of the review</h3><div>We summarize and meta-analyze metabolomics research on AF in human plasma and serum, atrial tissue, and animal models. We present the current progress on metabolic biomarkers candidates, metabolic features of clinical AF, and the translation of metabolomics findings from animal to human. We additionally discuss strengths and weaknesses of the metabolomics method and highlight opportunities for future AF metabolomics research.</div></div>","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"197 ","pages":"Pages 108-124"},"PeriodicalIF":4.9,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of molecular and cellular cardiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1